this article has been archived; content may be out of date.
#e4pMCM: the best bits from Twitter
|18th September 2014
The eyeforpharma Multichannel Marketing Summit, held at Victoria Park Plaza hotel, brought together pharma's marketing community who were all keen to learn how to enhance their current multichannel strategy. We've been following #e4pMCM to bring you the best bits of the conference, as it happened on Twitter:
Bert van Eijk @Boehringer talks #multichannel#marketing & #oncology#cancer@eyeforpharma#e4pMCM#e4pVASpic.twitter.com/BDtdB2kThu — PharmaTelevision (@PharmaTV) September 17, 2014Join it all together so that you can make decisions based on the evidence. #e4pmcmpic.twitter.com/yKwTZGWeYo — Wilf ILIFFE (@wilf66) September 17, 2014
People still think bad pharma, but there is opportunity to build trust using digital data. Context and strategy is crucial, hears #e4pMCM — Selina McKee (@PTSelinaMcKee) September 17, 2014#e4pmcm@SusSchaeffer pointing out we hide behind regulation. Eg. In SM listening — Kay Wesley (@KayWesley) September 18, 2014Chris Metzger says "Your desk is the worst place from which to view the world" - totally agree #e4pMCM — Beth Moore (@BethLMoore) September 18, 2014Ben from @bmorecreative24 discussing (and wearing!) how google glass & wearable tech will change healthcare #e4pMCMpic.twitter.com/ddqiTU7ksY — Polly Lutter (@polwar13) September 17, 2014Interesting that GPs are looking for similar information/capabilities in different places. Some inefficiencies being discussed. #e4pMCM — Gareth Dabbs (@garethdabbs) September 18, 2014A key way patients make decisions about their therapies is by talking to each other #e4pMCM — ThePharmaLetter (@ThePharmaLetter) September 18, 2014"If it's not improving the experience why are we doing it?" says @PharmaCXM. Great question #e4pMCM — Rebecca Belton (@beckybelton) September 17, 2014GP says 'I'm a human being not a segment'-be open & transparent,allow us to be professionals & balance risks & benefits #e4pMCM — Julie O'Donnell (@julieodonn) September 18, 2014Best session yet - 2 UK GPs talking about value of reps, digital, MCM: "focus on confidence transfer - not how great your drug is" #e4pMCM — Polly Lutter (@polwar13) September 18, 2014#e4pmcm iPad detailing cannot replace experience and knowledge from reps - just being there to navigate the slides is not the way forward. — Chris Wade (@wadoinlondon) September 18, 2014'Why can't I speak to the person who knows most about the medication' very true. #e4pMCM — Gareth Dabbs (@garethdabbs) September 18, 2014Another wow experience here at #e4pMCM: pfizer showing results from remote rep project! Go figure!! pic.twitter.com/8Lg6dMPpBX — Susanne Schäffer (@SusSchaeffer) September 17, 2014Patient panel: it doesn't matter thru what channel we communicate - we have try the patients shoes #e4pMCM — Nataliya Andreychuk (@nataliaand) September 18, 2014There's no denying that the main topic for discussion at the conference was around patient-centricity and the importance of finding out what is it that your customer needs, before designing a product or service for them.
If you’d like to discuss how we can help you meet your own challenges, call us on +44 203 328 1840 or contact us via email at hello@bluelatitude.com.
Marketing insights from digital analytics
|12th July 2018
Senior Associate Consultant Jiayi Chen gives her tips on using data analytics to better understand complex markets.
What do you do with your healthcare marketing data?
|9th July 2018
Pharma marketers are now spending more on data analysis than ever before. However, many are struggling to see a return on investment. BLH sits down with four BOBI Analyst of the Year 2018 finalists to find out how they turn data into insights that make a real difference to the success of pharma brands.
Training the next generation of biotech leaders
|4th July 2018
Blue Latitude Health speaks to Dr Ivan Wall, Reader in Cell & Gene Therapy Bioprocessing at University College London, to find out about the future of cell and gene therapy, the impact of Brexit, and how the next generation is paving the way for innovation.